AG
MEDP icon

Aperio Group’s Medpace MEDP Stock Holding History

Aperio Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.18M Sell
8,492
-266
-3% -$33.5K ﹤0.01% 1499
2020
Q3 		$979K Buy
8,758
+891
+11% +$103K ﹤0.01% 1447
2020
Q2 		$732K Sell
7,867
-143
-2% -$12.2K ﹤0.01% 1565
2020
Q1 		$588K Buy
8,010
+2,609
+48% +$226K ﹤0.01% 1567
2019
Q4 		$454K Sell
5,401
-635
-11% -$49.1K ﹤0.01% 1860
2019
Q3 		$507K Buy
6,036
+2,767
+85% +$209K ﹤0.01% 1753
2019
Q2 		$214K Buy
+3,269
New +$188K ﹤0.01% 2156

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Aperio Group's MEDP Position: Q4 2020 in Review

Aperio Group reduced its Medpace (MEDP) stake by 3% in Q4 2020, selling an estimated $33.5K and leaving 8,492 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1499.

Aperio Group first reported a position in MEDP in Q2 2019 and has held it in 7 quarters since. 316 funds tracked by Wall St. Rank hold MEDP as of Q4 2020.

  • Aperio Group held 8,492 shares of Medpace worth $1.18M as of Q4 2020.
  • Aperio Group sold 266 Medpace shares in Q4 2020, an estimated $33.5K.
  • Medpace made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1499 holding.
  • Aperio Group first reported a position in Medpace in Q2 2019 and has held it in 7 quarters since.
  • 316 funds tracked by Wall St. Rank held Medpace as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.